Posts Tagged ‘Asia’

ASX Company News: Vocus Communications Expands To Singapore

Thursday, November 24th, 2011

Vocus Communications (VOC) has announced the further expansion of its international plans by establishing a Vocus Point of Presence (PoP) in Singapore. The expansion is underpinned by the acquisition of capacity on the SeaMeWe-3 Perth to Singapore cable system. The expansion is a significant milestone as it enables Vocus to provide customers with access to the lowest latency and only direct path between Australia and South East Asia, with all other Asian submarine systems going via Guam or Japan. The new PoP in Singapore is located in the Equinix data centre and connects directly back to the Vocus’ Perth iX data centre via capacity on the SeaMeWe-3 cable system. The Vocus Singapore expansion is now live and Vocus has already signed its first major customer for the service.

James Spenceley, Vocus CEO, explains that the new PoP and capacity will deliver faster connection speeds to important content and corporate hubs in South East Asia and will be specifically very attractive to the banking and finance markets. “Our customers will see reduced latency and improved performance to all major destinations in South East Asia. With the growing demand for Ethernet and IP connectivity to countries such as Singapore and Hong Kong, there’s no doubt that this faster connection will have a very positive impact on both our current and potential customers,” he said.

Vocus (VOC) Vocus Communications is an ASX listed leading telecommunications provider of Data Centre, Dark Fibre, and International Internet connectivity across Australia, NZ and the US. The company provides high performance, high availability, and highly scalable communications solutions, which allow service providers to quickly and easily deploy new services for their own customer base.

www.vocus.com.au

http://www.traderdealer.com.au/fundamentals/voc

Post to Twitter

ASX Company News: Phosphagenics Enters Asian Distribution Agreement

Wednesday, August 3rd, 2011

Melbourne biotechnology company Phosphagenics Limited (POH) has signed an agreement with a leading Asian distributor ensuring its Elixia® personal care range will be available in stores across the Asia Pacific region by the fourth quarter, 2011. The milestone distribution deal has been struck with the Sungate Supplies Pte Ltd, which will exclusively supply AS Watson and Company stores commencing in Singapore. A.S. Watson & Co. is a retail and consumer division of the Hong Kong based conglomerate Hutchison Whampoa Ltd, and over the past decade has become the  largest health and beauty retailer in the world with over 7,000 stores.

Announcing the agreement, Phosphagenics CEO, Dr Esra Ogru, said while the Elixia® ranges had recently achieved Australian sales target of $1 million, the Asian region “is the fastest growing skincare market in the world. In 2010 skincare sales across the region generated $37.4 billion,” she noted. “We are very excited about this milestone. This is in-line with our strategy to become an international skincare brand. We are continuing to pursue other opportunities in the Asia region as well as Europe and the US. Phosphagenics is on track to meet its stated goal of becoming financially independent by the end of 2012” said Dr Ogru.

Elixia® is an Australian owned and developed brand which includes anti-ageing skincare formulas, specially developed to penetrate and target fine lines and wrinkles. The active anti-ageing ingredients include SNAP-8, Carnosine and CoQ10. TPM® is a patented world first delivery technology which enables superior penetration of these active ingredients into the skin.

Phosphagenics is commercialising drug delivery applications based on its novel transdermal (drugs administered via skin) TPM® – Targeted Penetration Matrix technology. TPM® is a patient friendly and cost effective system used to deliver proven pharmaceutical and nutraceutical products. The lead product advancing through clinical trials is an oxycodone matrix system for the relief of chronic pain.

www.phosphagenics.com

www.elixia.com.au

http://www.traderdealer.com.au/fundamentals/poh

Post to Twitter

ASX Company News: Phosphagenics Enters Asian Distribution Agreement

Thursday, July 7th, 2011

Phosphagenics Limited (POH) has signed an agreement with a leading Asian distributor ensuring its Elixia personal care range will be available in stores across the ® Asia Pacific region by the fourth quarter, 2011. The milestone distribution deal has been struck with the Sungate Supplies Pte Ltd, which will exclusively supply AS Watson and Company stores commencing in Singapore. A.S. Watson & Co. is a retail and consumer division of the Hong Kong based conglomerate Hutchison Whampoa Ltd, and over the past decade has become the largest health and beauty retailer in the world with over 7,000 stores.

Announcing the agreement, Phosphagenics CEO, Dr Esra Ogru, said while the Elixia ® ranges had recently achieved Australian sales target of $1 million, the Asian region “is the fastest growing skincare market in the world.   In 2010 skincare sales across the region generated $37.4 billion,” she noted. “We are very excited about this milestone.  This is in-line with our strategy to become an international skincare brand.  We are continuing to pursue other opportunities in the Asia region as well as Europe and the US.  Phosphagenics is on track to meet its stated goal of becoming financially independent by the end of 2012” said Dr Ogru.  Cathy Yeap, the Managing Director of AS Watson, Singapore said “We are very excited to be involved in the Asian launch of Elixia® through our stores and we anticipate that we will replicate the very successful launch of the products in Australia.”

Phosphagenics is commercialising drug delivery applications based on its novel transdermal (drugs administered via skin) TPM® – Targeted Penetration Matrix technology.  TPM® is a patient friendly and cost effective system used to deliver proven

pharmaceutical and nutraceutical products. The lead product advancing through clinical trials is an oxycodone matrix system for the relief of chronic pain.

www.phosphagenics.com

www.elixia.com.au

http://www.traderdealer.com.au/fundamentals/poh

Post to Twitter